Compositions and methods for treating disorders affecting motor function, such as motor function affected by disease or injury to the brain and/or spinal cord, are disclosed.

Edits on 25 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 25 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=1036919300

Edits on 6 Apr, 2023

"Entity importer update"

Golden AI

edited on 6 Apr, 2023

Infobox

Is a

Patent

Patent Applicant

Genzyme

Current Assignee

Genzyme

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

103691930

Date of Patent

August 6, 2019

Patent Application Number

151609490

Date Filed

May 20, 2016

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=103691930

Patent Citations Received

‌

US Patent 10745447 Methods and compositions for antibody-evading virus vectors

‌

US Patent 10821154 Compositions and methods for treating spinal muscular atrophy

Patent Primary Examiner

‌

James D Schultz

Edits on 30 Mar, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 30 Mar, 2023

Infobox

Patent Citations Received

‌

US Patent 10745447 Methods and compositions for antibody-evading virus vectors

Edits on 26 Sep, 2022

"update citations for inverse infoboxes"

Golden AI

edited on 26 Sep, 2022

Infobox

Patent Citations Received

‌

US Patent 10745447 Methods and compositions for antibody-evading virus vectors

Edits on 25 Sep, 2022

"Entity importer update"

Golden AI

edited on 25 Sep, 2022

Infobox

Is a

Patent

Patent Applicant

Genzyme

Current Assignee

Genzyme

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

103691930

Date of Patent

August 6, 2019

Patent Application Number

151609490

Date Filed

May 20, 2016

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=103691930

Patent Citations Received

‌

US Patent 10745447 Methods and compositions for antibody-evading virus vectors

‌

US Patent 10821154 Compositions and methods for treating spinal muscular atrophy

Patent Primary Examiner

‌

James D Schultz

Edits on 18 Jun, 2022

"Entity importer update"

Golden AI

edited on 18 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=10369193

Edits on 7 Feb, 2022

"update inverses"

Golden AI

edited on 7 Feb, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

‌

US Patent 10821154 Compositions and methods for treating spinal muscular atrophy

Edits on 6 Feb, 2022

"update inverses"

Golden AI

edited on 6 Feb, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

‌

US Patent 10745447 Methods and compositions for antibody-evading virus vectors

Edits on 27 Jan, 2022

"Created via: Entity Importer"

Golden AI

created this topic on 27 Jan, 2022

Edits made to:

Infobox (+9 properties)

‌

US Patent 10369193 Gene therapy for neurodegenerative disorders

Infobox

Is a

Patent

Patent applicant

Genzyme

Current assignee

Genzyme

Patent jurisdiction

United States Patent and Trademark Office

Patent number

10369193

Date of patent

August 6, 2019

Patent application number

15160949

Date Filed

May 20, 2016

Patent primary examiner

‌

James D Schultz

Find more entities like US Patent 10369193 Gene therapy for neurodegenerative disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API